8-K: VSee Health Secures $271,739 Note Financing

VSee Health, Inc. has entered into a securities purchase agreement to issue a secured promissory note to an institutional investor, ADI Funding LLC, for $271,739.13.

Summary

• VSee Health, Inc. (the Company) entered into a Securities Purchase Agreement (SPA) with ADI Funding LLC (the Holder) on June 8, 2026.
• The Company issued an 8% original issue discount secured promissory note to the Holder for an aggregate principal amount of $271,739.13.
• The Promissory Note bears an interest rate of 18% per annum and is due on December 8, 2026.
• The note is secured by certain assets of the Company.
• The Company has the right to prepay any portion of the outstanding balance with a 10% prepayment fee, unless an Event of Default has occurred.
• Upon receipt of proceeds from an equity line of credit financing arrangement with the Holder, the Company must repay the entire outstanding balance within two business days.
• The issuance of the note is exempt from registration under the Securities Act of 1933, pursuant to Section 4(a)(2) and/or Regulation D.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as having a negative sentiment due to the high cost of financing (18% interest, 8% discount, 10% prepayment fee) and the secured nature of the debt, indicating potential financial distress.

Positives

• Secured necessary financing to continue operations.
• The financing is structured as a promissory note, which may offer more flexibility than immediate equity dilution.
• The company has the right to prepay the note, potentially allowing for early repayment if financial conditions improve.
• The note is secured, which may have been a condition for the investor to provide funding.

Negatives

• The note carries a high interest rate of 18% per annum.
• There is an 8% original issue discount, meaning the effective loan amount is $250,000 for a $271,739.13 principal.
• A 10% prepayment fee is required if the company chooses to repay early.
• The note must be repaid within two business days of receiving proceeds from an equity line of credit, potentially forcing a rapid repayment schedule.
• The note is secured by company assets, which could be at risk if the company defaults.

Risks

• High interest rate (18% per annum) increases the cost of capital.
• The requirement to repay the entire note upon receipt of ELOC proceeds could create a liquidity crunch if ELOC proceeds are delayed or insufficient.
• The note is secured by company assets, posing a risk of asset seizure in case of default.
• The 10% prepayment penalty could deter early repayment even if financially advantageous.
• Events of Default, including failure to make payments or breaches of covenants, can lead to accelerated repayment and potentially higher default interest rates (up to 28%).

Future Outlook

The company is required to file a registration statement on Form S-1 for an equity line of credit financing arrangement by June 11, 2026. The proceeds from this ELOC are intended to be used for repayment of the current promissory note.

Industry Context

StockSavvy.ai notes that VSee Health's reliance on debt financing with high interest rates and discounts is common for companies in challenging financial positions or early stages of development seeking to avoid immediate equity dilution. The terms suggest a need for capital that may not be readily available through traditional equity markets.

Stakeholder Impact

• Shareholders: Potential for future dilution if the ELOC is converted into equity. The high cost of debt could impact profitability and future share value. Secured debt poses a risk to asset value.
• Creditors: The note is secured by company assets, potentially impacting the priority of other creditors in case of default.
• Investors (ADI Funding LLC): The investor has secured debt with a high interest rate and discount, and a clear path to repayment via ELOC proceeds.

Next Steps

• File registration statement on Form S-1 for ELOC financing by June 11, 2026.
• File a Current Report on Form 8-K related to the ELOC by June 11, 2026.
• Provide irrevocable transfer agent instructions for commitment shares to M2B Funding Corp. by June 11, 2026.
• Repay the entire outstanding balance of the Promissory Note within two business days of receiving proceeds from the ELOC.

Key Dates

Recommendation

The financing provides immediate liquidity but comes at a high cost, indicating potential financial strain. The company's ability to execute its ELOC strategy and manage its debt obligations will be critical. Investors should monitor the ELOC filing and subsequent capital raise closely.

Keywords

VSee Health, 8-K, Securities Purchase Agreement, Promissory Note, Debt Financing, ADI Funding LLC, Equity Line of Credit, SEC Filing